Clune & Associates, Ltd. Abbott Laboratories Transaction History
Clune & Associates, Ltd.
- $301 Billion
- Q4 2024
A detailed history of Clune & Associates, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Clune & Associates, Ltd. holds 14,541 shares of ABT stock, worth $1.91 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
14,541Holding current value
$1.91 Million% of portfolio
0.55%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,275Shares Held
1.31BCall Options Held
9.63MPut Options Held
8.36M-
Vanguard Group Inc Valley Forge, PA169MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$10.1 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.64 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$7.01 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $230B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...